Yan X - Search Results

1

Bicontinuous Block Copolymer Microparticles through Hydrogen-Bonding-Mediated Dual Phase Separation between Polymer Segments and Fluorinated Additives.

Ren M, Zhang M, Hou Z, Yan X, Zhang L, Xu J, Zhu J. Ren M, et al. Among authors: yan x. ACS Nano. 2024 Dec 22. doi: 10.1021/acsnano.4c13152. Online ahead of print. ACS Nano. 2024. PMID: 39711067

2

The characteristics of phthalate acid esters and bisphenol A in PM_2.5 of a petrochemical city: Concentrations, compositions, and health risk assessment in Dongying.

Long F, Ren Y, Ji Y, Bai X, Li H, Wang G, Yan X, Chen Y, Li J, Zhang H, Gao R, Bi F, Wu Z. Long F, et al. Among authors: yan x. Environ Pollut. 2024 Dec 20:125568. doi: 10.1016/j.envpol.2024.125568. Online ahead of print. Environ Pollut. 2024. PMID: 39710181

3

Developing a Ni-grafted magnetic nanoparticle for direct CotA capture in rapid detoxification of aflatoxin B1.

Zhang C, Wang D, Wang C, Yu H, Zhong P, Dang W, Yang Y, Wang Y, Yan X. Zhang C, et al. Among authors: yan x. J Hazard Mater. 2024 Dec 9;485:136829. doi: 10.1016/j.jhazmat.2024.136829. Online ahead of print. J Hazard Mater. 2024. PMID: 39708604

4

Exploring the molecular mechanisms for renoprotective effects of Huangkui capsule on diabetic nephropathy mice by comprehensive serum metabolomics analysis.

Yan X, Li P, Liu C, Yin F, Han J, Sun H, Zheng Y, Chen X, Guan S, Wang X. Yan X, et al. J Ethnopharmacol. 2024 Dec 18;340:119223. doi: 10.1016/j.jep.2024.119223. Online ahead of print. J Ethnopharmacol. 2024. PMID: 39706356

5

Astragaloside IV ameliorates atherosclerosis by targeting TAK1 to suppress endothelial cell proinflammatory activation.

Hua S, Zhang H, Li J, Zhou X, Zhang S, Zhu Y, Yan X, Gu P, Huang Z, Jiang W. Hua S, et al. Among authors: yan x. Int Immunopharmacol. 2024 Dec 19;146:113842. doi: 10.1016/j.intimp.2024.113842. Online ahead of print. Int Immunopharmacol. 2024. PMID: 39706043

6

Development and application of a novel scintillation gel-based 3D dosimetry system for radiotherapy.

Li H, Jin H, He L, Yan X, Zhang H, Li D. Li H, et al. Among authors: yan x. J Appl Clin Med Phys. 2024 Dec 20:e14615. doi: 10.1002/acm2.14615. Online ahead of print. J Appl Clin Med Phys. 2024. PMID: 39704638

7

Advanced Mass-Spectra-Based Machine Learning for Predicting the Toxicity of Traditional Chinese Medicines.

Jia C, Li X, Hu S, Liu G, Fang J, Zhou X, Yan X, Yan B. Jia C, et al. Among authors: yan x. Anal Chem. 2024 Dec 20. doi: 10.1021/acs.analchem.4c05311. Online ahead of print. Anal Chem. 2024. PMID: 39704481

8

Effect of comprehensive intervention model based on drug-psychology-society-skills on medication compliance and cognitive ability of chronic schizophrenia patients.

Wang HJ, Chen W, Yan XL, Huang QY, Xu WD. Wang HJ, et al. Among authors: yan xl. World J Psychiatry. 2024 Dec 19;14(12):1947-1955. doi: 10.5498/wjp.v14.i12.1947. eCollection 2024 Dec 19. World J Psychiatry. 2024. PMID: 39704380 Free PMC article.

9

YAP/TAZ mediates resistance to KRAS inhibitors through inhibiting proapoptosis and activating the SLC7A5/mTOR axis.

Yang W, Zhang M, Zhang TX, Liu JH, Hao MW, Yan X, Gao H, Lei QY, Cui J, Zhou X. Yang W, et al. Among authors: yan x. JCI Insight. 2024 Dec 20;9(24):e178535. doi: 10.1172/jci.insight.178535. JCI Insight. 2024. PMID: 39704172 Free article.

10

Mitochondrial DNA-activated cGAS-STING pathway in cancer: Mechanisms and therapeutic implications.

Xia L, Yan X, Zhang H. Xia L, et al. Among authors: yan x. Biochim Biophys Acta Rev Cancer. 2024 Dec 17;1880(1):189249. doi: 10.1016/j.bbcan.2024.189249. Online ahead of print. Biochim Biophys Acta Rev Cancer. 2024. PMID: 39701325 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,889 results

Search Page

Filters